Agilent Technologies Inc. (A) Introduces HaloPlex Next-Generation Sequencing Panels Targeting Cancer and Inherited Diseases for Research
6/11/2013 9:49:52 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced a new series of HaloPlex next-generation sequencing panels targeting specific disease states. Two catalog products, the HaloPlex Cancer Research Panel and the HaloPlex Cardiomyopathy Research Panel, plus five predesigned research panels for arrhythmia, ICCG genomic regions, X chromosome, Noonan syndrome, and connective tissue disorders are now available. Used in combination with Agilent’s SureDesign and SureCall software, the new panels enable laboratories to perform integrated data analysis, mapping and reporting with greater confidence, speed and flexibility.
Help employers find you! Check out all the jobs and post your resume.